Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
300 participants
OBSERVATIONAL
2025-08-07
2026-04-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Prognosis and Predicting Genetic Study of Lung Cancer
NCT03234179
Effects of Nurse-led Supportive Care Programme on Caregiver Burden and Resilience of Family Caregivers
NCT06204289
The Prognostic and Predictive Value of the CA-125 Marker in Lung Cancer Monitoring
NCT02437760
Lung Resection and Pulmonary Rehabilitation
NCT04722393
The Impact of Polynuclear Neutrophils' Intra-tumoral Rate and the Mutational Status in Pulmonary Adenocarcinomas on Survival
NCT04761640
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Moreover, a large proportion of people living in low and middle income countries are exposed to secondhand smoke (SHS) in their homes, workplaces, and other public places.
Although, lung cancer had become one of fatality causes of the 20th century due to an increasing life span combined with exposures to various etiologic factors, it is one of the leading causes of preventable deaths.
There are various important risk factors other than tobacco smoking that can contribute substantially to the lung cancer mortality in never smokers; these other lung carcinogens often act in an additive or synergistic manner in individuals who smoke tobacco products.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
bronchogenic carcinoma in female patients
A retrospective cohort study will be conducted on bronchogenic carcinoma female patients who had been presented to and diagnosed at chest diseases department, Oncology Center Mansoura University (OCMU).
Demographics and risk factors of lung cancer
A retrospective cohort study will be conducted on bronchogenic carcinoma patients who had been presented to and diagnosed at chest diseases department, Oncology Center Mansoura University (OCMU).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Demographics and risk factors of lung cancer
A retrospective cohort study will be conducted on bronchogenic carcinoma patients who had been presented to and diagnosed at chest diseases department, Oncology Center Mansoura University (OCMU).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mansoura University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mohamed Abd Elmoniem Mohamed
Lecturer of chest medicine faculty of medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mohamed AbdElmoniem
Role: PRINCIPAL_INVESTIGATOR
Lecturer of chest medicine faculty of medicine Mansoura university
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mohamed AbdElmoniem
Al Mansurah, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Mohamed Mansour
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R.25.07.3275
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.